Cargando…

Very rare thrombosis with thrombocytopenia after second AZD1222 dose: a global safety database analysis

Detalles Bibliográficos
Autores principales: Bhuyan, Prakash, Medin, Jennie, da Silva, Hugo Gomes, Yadavalli, Madhavi, Shankar, Nirmal Kumar, Mullerova, Hana, Arnold, Matthew, Nord, Magnus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9753120/
https://www.ncbi.nlm.nih.gov/pubmed/34329583
http://dx.doi.org/10.1016/S0140-6736(21)01693-7
_version_ 1784850896913432576
author Bhuyan, Prakash
Medin, Jennie
da Silva, Hugo Gomes
Yadavalli, Madhavi
Shankar, Nirmal Kumar
Mullerova, Hana
Arnold, Matthew
Nord, Magnus
author_facet Bhuyan, Prakash
Medin, Jennie
da Silva, Hugo Gomes
Yadavalli, Madhavi
Shankar, Nirmal Kumar
Mullerova, Hana
Arnold, Matthew
Nord, Magnus
author_sort Bhuyan, Prakash
collection PubMed
description
format Online
Article
Text
id pubmed-9753120
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-97531202022-12-15 Very rare thrombosis with thrombocytopenia after second AZD1222 dose: a global safety database analysis Bhuyan, Prakash Medin, Jennie da Silva, Hugo Gomes Yadavalli, Madhavi Shankar, Nirmal Kumar Mullerova, Hana Arnold, Matthew Nord, Magnus Lancet Correspondence Elsevier Ltd. 2021 2021-07-27 /pmc/articles/PMC9753120/ /pubmed/34329583 http://dx.doi.org/10.1016/S0140-6736(21)01693-7 Text en © 2021 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Correspondence
Bhuyan, Prakash
Medin, Jennie
da Silva, Hugo Gomes
Yadavalli, Madhavi
Shankar, Nirmal Kumar
Mullerova, Hana
Arnold, Matthew
Nord, Magnus
Very rare thrombosis with thrombocytopenia after second AZD1222 dose: a global safety database analysis
title Very rare thrombosis with thrombocytopenia after second AZD1222 dose: a global safety database analysis
title_full Very rare thrombosis with thrombocytopenia after second AZD1222 dose: a global safety database analysis
title_fullStr Very rare thrombosis with thrombocytopenia after second AZD1222 dose: a global safety database analysis
title_full_unstemmed Very rare thrombosis with thrombocytopenia after second AZD1222 dose: a global safety database analysis
title_short Very rare thrombosis with thrombocytopenia after second AZD1222 dose: a global safety database analysis
title_sort very rare thrombosis with thrombocytopenia after second azd1222 dose: a global safety database analysis
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9753120/
https://www.ncbi.nlm.nih.gov/pubmed/34329583
http://dx.doi.org/10.1016/S0140-6736(21)01693-7
work_keys_str_mv AT bhuyanprakash veryrarethrombosiswiththrombocytopeniaaftersecondazd1222doseaglobalsafetydatabaseanalysis
AT medinjennie veryrarethrombosiswiththrombocytopeniaaftersecondazd1222doseaglobalsafetydatabaseanalysis
AT dasilvahugogomes veryrarethrombosiswiththrombocytopeniaaftersecondazd1222doseaglobalsafetydatabaseanalysis
AT yadavallimadhavi veryrarethrombosiswiththrombocytopeniaaftersecondazd1222doseaglobalsafetydatabaseanalysis
AT shankarnirmalkumar veryrarethrombosiswiththrombocytopeniaaftersecondazd1222doseaglobalsafetydatabaseanalysis
AT mullerovahana veryrarethrombosiswiththrombocytopeniaaftersecondazd1222doseaglobalsafetydatabaseanalysis
AT arnoldmatthew veryrarethrombosiswiththrombocytopeniaaftersecondazd1222doseaglobalsafetydatabaseanalysis
AT nordmagnus veryrarethrombosiswiththrombocytopeniaaftersecondazd1222doseaglobalsafetydatabaseanalysis